Asunto(s)
Enfermedades del Desarrollo Óseo/genética , Errores Innatos del Metabolismo/genética , Sustitución de Aminoácidos/genética , Enfermedades del Desarrollo Óseo/diagnóstico por imagen , Glicosilación , Humanos , Recién Nacido , Errores Innatos del Metabolismo/diagnóstico por imagen , Fosfotransferasas (Fosfomutasas)/genética , RadiografíaRESUMEN
Fifty-two total ear canal ablation (TECA) procedures in 44 cats were reviewed. The indication for surgery was neoplasia in 41 per cent of the cats, 86 per cent of which had ceruminous gland adenocarcinoma. Chronic inflammatory or polypoid disease accounted for 50 per cent of surgical procedures. Postoperative complications included Horner's syndrome (42 per cent) and facial paralysis (56 per cent) and these were permanent in 14 per cent and 28 per cent of cases, respectively, with the rest resolving in the ensuing weeks or months. The higher incidence of Horner's syndrome and facial paralysis in the cat, compared to the dog, was attributed to greater fragility of the feline tympanic plexus and facial nerve. The median survival time of cats with ceruminous gland adenocarcinoma was 50-3 months, and did not differ significantly from that for inflammatory or polypoid disease. A potential prognostic indicator for this tumour was the mitotic index (MI): cases with MI < or = 2 survived significantly longer than those with MI > or = 3.
Asunto(s)
Adenocarcinoma/veterinaria , Enfermedades de los Gatos/mortalidad , Enfermedades de los Gatos/cirugía , Conducto Auditivo Externo/cirugía , Neoplasias del Oído/veterinaria , Adenocarcinoma/mortalidad , Adenocarcinoma/cirugía , Animales , Enfermedades de los Gatos/patología , Gatos , Neoplasias del Oído/mortalidad , Neoplasias del Oído/cirugía , Inglaterra/epidemiología , Parálisis Facial/veterinaria , Femenino , Síndrome de Horner/veterinaria , Masculino , Complicaciones Posoperatorias/veterinaria , Pronóstico , Registros/veterinaria , Estudios Retrospectivos , Análisis de SupervivenciaRESUMEN
Flat-Coated Retrievers seem to be at increased risk of developing soft-tissue sarcomas, and undifferentiated round cell or spindle cell sarcomas account for approximately 59% of sarcomas in the breed. In an attempt to classify these tumors further, formalin-fixed, paraffin-embedded sections from 14 undifferentiated sarcomas from Flat-Coated Retrievers were reviewed and examined with a panel of histologic and immunohistochemical stains. The panel included vimentin, desmin, Myo D1, smooth muscle actin, cytokeratin, S100, von Willebrand factor (factor VIII), Mac 387, CD3, major histocompatibility complex (MHC) class II, and CD79a. The majority of the sarcomas showed greater than 70% staining for MHC class II. We conclude that these undifferentiated sarcomas in Flat-Coated Retrievers belong to a spectrum of tumors with varying proportions of characteristic cell types and morphologic features, some of which fit the diagnostic criteria for malignant fibrous histiocytoma. Many of these sarcomas seem to have a significant myofibroblast component and a mild or moderate T cell infiltrate but the precise cell lineage is still uncertain.
Asunto(s)
Enfermedades de los Perros/patología , Histiocitoma Fibroso Benigno/veterinaria , Neoplasias de los Tejidos Blandos/veterinaria , Animales , Enfermedades de los Perros/metabolismo , Perros , Histiocitoma Fibroso Benigno/metabolismo , Histiocitoma Fibroso Benigno/patología , Inmunohistoquímica/veterinaria , Neoplasias de los Tejidos Blandos/metabolismoRESUMEN
This paper presents the results of a prospective study to investigate the prognostic value of clinical staging, histological grading, immunophenotype, mitotic count and average numbers of argyrophilic nucleolar organiser region counts in dogs with multicentric lymphosarcoma treated with a standard chemotherapy protocol comprising vincristine, cyclophosphamide and prednisolone. Forty-nine dogs were treated according to the study protocol. Univariate and multivariate analysis with regression modelling was used to evaluate the prognostic importance of patient and tumour variables upon tumour response and relapse-free survival. Thirty-seven dogs (76 per cent) achieved a complete remission, seven (14 per cent) a partial remission and five (10 per cent) failed to respond to treatment. None of the variables examined had a statistically significant effect upon tumour response. Tumour immunophenotype was the only parameter found to have a significant influence on patient survival, the hazard ratio for T-cell versus B-cell immunophenotype was 3.99 with 95 per cent confidence interval from 1.399 to 11.372, P = 0.035.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Enfermedades de los Perros/tratamiento farmacológico , Enfermedades de los Perros/mortalidad , Linfoma no Hodgkin/veterinaria , Animales , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Ciclofosfamida/administración & dosificación , Supervivencia sin Enfermedad , Enfermedades de los Perros/inmunología , Perros , Femenino , Inmunofenotipificación/veterinaria , Linfoma no Hodgkin/tratamiento farmacológico , Linfoma no Hodgkin/mortalidad , Masculino , Prednisona/administración & dosificación , Pronóstico , Modelos de Riesgos Proporcionales , Resultado del Tratamiento , Vincristina/administración & dosificaciónRESUMEN
Over the period from March 1990 to December 1998, veterinary surgeons in general practice were invited to submit tissues suspected of being neoplastic which had been removed from flat-coated retrievers. When possible, pedigree details were obtained from the owners. In addition, data were collected from flat-coated retrievers known to have suffered from a neoplastic condition and for which a histopathological report was available. A total of 1023 submissions was obtained from 782 dogs. These included 165 non-neoplastic lesions (16 per cent), 447 benign samples (44 per cent) and 411 malignant samples (40 per cent). Soft tissue sarcomas accounted for 55 per cent of the malignant samples (26 per cent of all tumour samples and 22 per cent of all submissions) with 63 per cent of them being diagnosed as undifferentiated. Carcinomas accounted for 20 per cent of malignant samples (8 per cent of all submissions). Of the benign tumours, cutaneous histiocytoma was the most common diagnosis (48 per cent of benign tumours, 25 per cent of all tumours and 21 per cent of all submissions).
Asunto(s)
Enfermedades de los Perros/epidemiología , Enfermedades de los Perros/patología , Neoplasias/veterinaria , Animales , Diagnóstico Diferencial , Perros , Inglaterra/epidemiología , Femenino , Histiocitoma Fibroso Benigno/epidemiología , Histiocitoma Fibroso Benigno/patología , Histiocitoma Fibroso Benigno/veterinaria , Masculino , Neoplasias/epidemiología , Neoplasias/patología , Linaje , Sarcoma/epidemiología , Sarcoma/patología , Sarcoma/veterinaria , Neoplasias Cutáneas/epidemiología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/veterinaria , Neoplasias de los Tejidos Blandos/epidemiología , Neoplasias de los Tejidos Blandos/patología , Neoplasias de los Tejidos Blandos/veterinariaRESUMEN
The aim of this study was to investigate the prognostic importance of different clinical, immunohistologic and tumor proliferation characteristics in dogs with malignant lymphoma treated with chemotherapy. From 74 dogs with malignant lymphoma at least one enlarged peripheral lymph node was taken for biopsy before chemotherapy following a standardized protocol (vincristine, cyclophosphamide, prednisolone, doxorubicin, and L-asparaginase). The variables evaluated as prognostic factors were age, sex, and tumor stage, as well as histomorphologic grade (Kiel classification, Working Formulation), immunophenotype (using markers for CD3 and CD79a), and cell proliferation (Ki-67, proliferation cell nuclear antigen, mitotic index, and argyrophil nucleolar organizer regions [AgNORs]) in extirpated lymph nodes. All markers were used on routinely formalin-fixed, paraffin-embedded tissues. The AgNORs were assessed qualitatively, based on the AgNOR pattern distribution, and quantitatively using image analysis and routine counting. In both univariate and multivariate survival analyses, AgNORs were a valuable prognostic marker for the treatment of canine malignant lymphomas. Based on the results of the multivariate analysis longer survival time correlated with a B-cell type, a larger mean AgNOR area, a larger total AgNOR area, a shorter distance between two AgNORs, and a smaller AgNOR area to nucleus ratio. Longer disease-free survival time correlated with a smaller number of AgNORs per nucleus, a larger mean AgNOR area, a larger maximal AgNOR area, and a larger total AgNOR area. This study clearly demonstrates the additional benefit of the use of AgNORs in predicting treatment outcome in dogs with malignant lymphoma.
Asunto(s)
Antineoplásicos/uso terapéutico , Enfermedades de los Perros/patología , Linfoma/veterinaria , Análisis de Varianza , Animales , Enfermedades de los Perros/clasificación , Enfermedades de los Perros/tratamiento farmacológico , Perros , Femenino , Linfoma/clasificación , Linfoma/tratamiento farmacológico , Linfoma/patología , Masculino , Análisis Multivariante , Pronóstico , Antígeno Nuclear de Célula en Proliferación , Análisis de SupervivenciaRESUMEN
The behaviour of canine malignant lymphomas is difficult to predict on the basis of histomorphology alone, but the majority of such tumours are "high-grade" by most classifications. The aim of this study was to examine the prognostic significance of argyrophilic nucleolar organizer region (AgNOR) counts and of proliferating cell nuclear antigen (PCNA)-positive cell counts in canine malignant lymphomas; and to relate the results to the histological grade (Kiel classification) and to the survival time of treated and untreated dogs. Low- and high-grade malignant lymphomas differed significantly in having mean AgNOR counts of 3.3 and 5.7 respectively. Untreated dogs with a mean AgNOR count higher than 5.5 did not survive more than 85 days; the median survival time for this group was 38.5 days. Untreated dogs with a mean AgNOR count lower than 4.0 survived at least 82 days and one dog more than 300 days; the median survival time for this group was 154 days. Treated dogs with a mean AgNOR count higher than 5.5 did not survive more than 126 days; the median survival time for this group was 73.5 days. Treated dogs with a mean AgNOR count lower than 4.0 had a median survival time of 205.5 days and one dog survived 367 days. The mean AgNOR count would seem to be a valuable prognostic marker for canine malignant lymphomas, but PCNA counts had no prognostic significance in relation to the median survival time in treated or untreated dogs.
Asunto(s)
Enfermedades de los Perros/patología , Linfoma/veterinaria , Región Organizadora del Nucléolo , Antígeno Nuclear de Célula en Proliferación/análisis , Animales , Recuento de Células/veterinaria , Enfermedades de los Perros/mortalidad , Perros , Linfoma/mortalidad , Linfoma/patología , Pronóstico , Tasa de SupervivenciaRESUMEN
Ninety bitches with mammary tumours were studied for two years after the surgical removal of the primary tumour(s). Twenty-nine of the bitches had been spayed before the development of the mammary tumour, 22 were spayed when the tumours were removed and 39 were left entire. Fifty-eight of the bitches (64 per cent) had benign tumours and, of these, 15 (26 per cent) developed a new mammary tumour within two years, irrespective of whether the bitch was spayed. The other 32 bitches had malignant tumours which were grouped into 'invasive' and 'well defined' carcinomas. Sixty-three per cent of the spayed bitches and 57 per cent of the entire bitches, with invasive carcinoma were dead within two years of surgery as a result of their mammary tumours. For those with well defined carcinomas the tumour-related death rates were 18 per cent and 33 per cent respectively for the spayed and entire bitches. These findings suggest that ovariohysterectomy when mammary tumours are removed does not have a significant effect on the progression of malignant disease, and that about one in four bitches with a benign mammary tumour is likely to develop a further tumour in another gland.
Asunto(s)
Carcinoma/patología , Histerectomía/veterinaria , Neoplasias Mamarias Animales/patología , Ovariectomía/veterinaria , Animales , Carcinoma/terapia , Progresión de la Enfermedad , Perros , Femenino , Neoplasias Mamarias Animales/terapia , Neoplasias Primarias Secundarias/etiología , Neoplasias Primarias Secundarias/veterinariaRESUMEN
This article provides a conceptual model illustrating the filtering effect that social factors have on a health care event. Individual, family and social network filters translate the symptom for the patient before and after s/he enters the health care delivery system. Simultaneously, managed care and provider filters shape what resource is provided by the health care provider to the patient. Basic premises are that decision-making about health care utilization is a complex social interaction and that better attention to the social context will increase the likelihood of effective health care occurring.
Asunto(s)
Actitud Frente a la Salud , Toma de Decisiones , Recursos en Salud/estadística & datos numéricos , Modelos Teóricos , Sociología Médica , Humanos , Programas Controlados de Atención en Salud , Aceptación de la Atención de SaludRESUMEN
Ninety-three bitches which had undergone mammary tumour surgery were entered into a clinical trial to examine the effects of ovariohysterectomy (spaying) at the time of mammary surgery and the use of the drug tamoxifen in preventing the recurrence of the tumour and/or the development of new mammary tumours. Twenty-three of the bitches which had been spayed were allocated tamoxifen but only 18 of them complied with the treatment and in nine of these the treatment was stopped owing to side effects (mostly oestrogenic). Too few animals were studied to draw conclusions about the possible preventative effects of tamoxifen on mammary neoplasia, but the high percentage of bitches affected by oestrogen-like side effects may reduce the compliance of owners and prevent tamoxifen being widely used in dogs.
Asunto(s)
Enfermedades de los Perros/tratamiento farmacológico , Neoplasias Mamarias Animales/tratamiento farmacológico , Tamoxifeno/uso terapéutico , Animales , Quimioterapia Adyuvante , Enfermedades de los Perros/cirugía , Perros , Femenino , Histerectomía/veterinaria , Neoplasias Mamarias Animales/cirugía , Ovariectomía/veterinaria , Tamoxifeno/efectos adversos , Resultado del TratamientoRESUMEN
In this study, surgically excised mammary tumors from 98 bitches were graded histologically, and the grade was compared with the mean nucleolar organizer region (NOR) count in silver-stained paraffin-embedded sections. Histologically benign tumors, papillary adenocarcinomas, and intraductal carcinomas showed relatively little variation; the mean count for each category was between three and four NOR per nucleus. There was, however, a significant increase in the NOR counts in tubular and solid carcinomas. This increase was most pronounced for tumors that showed evidence of infiltration into the surrounding connective tissues. The mean NOR count for noninfiltrative carcinomas was 5.1, and that for invasive carcinomas was 7.3 (P less than 0.03). The mean NOR count for individual carcinomas ranged from 2.0 to 12.3, and a significant correlation was found between an increased NOR count and tumor-related death during the first post-surgical year. The 39 bitches in which the tumor had an NOR count less than 8.0 had a generally favorable prognosis; only six (15%) died as a result of the original neoplasm. In contrast, 18/21 dogs (85%) with a carcinoma having an NOR count greater than 8.0 died from the tumor during the first post-surgical year. A similar, although less pronounced result was obtained specifically for invasive carcinomas, in which 3/12 (25%) tumors with an NOR count less than 6.0 resulted in the death of the host, compared with 17/20 (85%) that had an NOR count greater than 6. By using this technique, it is possible to identify a subgroup of bitches with invasive mammary carcinomas that have a very poor prognosis following apparently adequate surgical ablation of the primary tumor.
Asunto(s)
Enfermedades de los Perros/patología , Neoplasias Mamarias Animales/ultraestructura , Región Organizadora del Nucléolo/patología , Animales , Enfermedades de los Perros/cirugía , Perros , Femenino , Neoplasias Mamarias Animales/patología , Neoplasias Mamarias Animales/cirugía , Pronóstico , Estudios ProspectivosRESUMEN
The average number of nucleolar organiser regions per cell has previously been shown to correlate well with histological grading techniques for a variety of neoplasms in man, and may thus be of value as an aid to post-surgical prognosis. In this study 50 spontaneously arising, subcutaneous canine mast cell tumours were graded and the histological grade compared with the mean AgNOR count. For well differentiated neoplasms the mean count was 1.4 per cell compared with 6.3 for poorly differentiated neoplasms, while tumours of intermediate differentiation had a mean count of 3.2 per cell. Subsequent follow up studies revealed that the AgNOR count was an accurate prognostic indicator, 73% of dogs with a high mean count (greater than 4.9) being destroyed from tumour related disease compared with 33% with an intermediate count (1.7-4.8). No dog with a count of less than 1.7 has been destroyed because of tumour recurrence to date and the AgNOR count has proved to be a better and more objective prognostic indicator than either histological tumour grade or mitotic index. Since most dogs which develop recurrent mast cell tumours do so within 6 months of initial surgery, an assessment of the predictive value of AgNORs can be obtained more quickly in canine tumours than for comparable human neoplasms.
Asunto(s)
Enfermedades de los Perros/patología , Sarcoma de Mastocitos/veterinaria , Región Organizadora del Nucléolo , Neoplasias Cutáneas/veterinaria , Animales , Enfermedades de los Perros/cirugía , Perros , Sarcoma de Mastocitos/cirugía , Sarcoma de Mastocitos/ultraestructura , Periodo Posoperatorio , Pronóstico , Neoplasias Cutáneas/cirugía , Neoplasias Cutáneas/ultraestructuraRESUMEN
Sialolithiasis occurs most commonly in the submandibular gland. The vast majority of salivary stones are single, with only 3 percent occurring bilaterally. Patients with distal submandibular stones may be treated with simple sialolithotomy. Other causes of salivary gland enlargement include mumps, tumors, acute suppurative sialadenitis and granulomatous disease.
Asunto(s)
Cálculos del Conducto Salival , Enfermedades de las Glándulas Salivales , Enfermedades de la Glándula Submandibular , Adulto , Anciano , Diagnóstico Diferencial , Humanos , Masculino , Persona de Mediana Edad , Recurrencia , Cálculos del Conducto Salival/diagnóstico , Cálculos del Conducto Salival/cirugía , Enfermedades de las Glándulas Salivales/diagnóstico , Enfermedades de las Glándulas Salivales/cirugía , Enfermedades de la Glándula Submandibular/diagnóstico , Enfermedades de la Glándula Submandibular/cirugíaRESUMEN
Seventy-five surgically excised canine gum neoplasms, which had previously been diagnosed as epulis or ameloblastoma, were reclassified on the basis of their presumed tissue of origin. They included 42 tumours of fibroblastic origin, which contained small foci of odontogenic epithelium and were classified as peripheral odontogenic fibroma, whilst 31 epithelial tumours were classified as basal cell carcinomas arising from the gum epithelium. Two epithelial tumours which apparently arose within the bone of the mandible and were not connected with the surface mucosa were classified as ameloblastomas. Follow-up studies after surgery revealed a recurrence rate of 17 per cent for the odontogenic fibromas and 50 per cent for basal cell carcinomas. Neither of the ameloblastomas, which were initially treated by radical excision, recurred locally and no metastases were detected from any of these tumours.
Asunto(s)
Ameloblastoma/veterinaria , Carcinoma Basocelular/veterinaria , Enfermedades de los Perros/clasificación , Neoplasias Gingivales/veterinaria , Tumores Odontogénicos/veterinaria , Ameloblastoma/clasificación , Ameloblastoma/patología , Animales , Carcinoma Basocelular/clasificación , Carcinoma Basocelular/patología , Enfermedades de los Perros/diagnóstico por imagen , Enfermedades de los Perros/fisiopatología , Enfermedades de los Perros/cirugía , Perros , Neoplasias Gingivales/clasificación , Neoplasias Gingivales/fisiopatología , Neoplasias Gingivales/cirugía , Tumores Odontogénicos/clasificación , Tumores Odontogénicos/patología , Periodo Posoperatorio , Radiografía , Terminología como AsuntoRESUMEN
The variation in prevalence of neoplasms over time and location has been of value in identifying environmental carcinogens. Studies on the relative frequency of the different histological types of canine oropharyngeal malignant neoplasm have shown that squamous cell carcinoma of the tonsil occurs four times more commonly in south east England, and twice as frequently in the United States of America as in Melbourne, Australia. The prevalence of tonsillar squamous cell carcinoma in London in 1950 was 15 times greater than that currently experienced in Melbourne and four times greater than that now found in other areas of south east England.
Asunto(s)
Enfermedades de los Perros/epidemiología , Neoplasias Faríngeas/veterinaria , Animales , Australia , Carcinoma de Células Escamosas/epidemiología , Carcinoma de Células Escamosas/veterinaria , Perros , Neoplasias Faríngeas/epidemiología , Neoplasias Tonsilares/epidemiología , Neoplasias Tonsilares/veterinaria , Reino Unido , Estados UnidosAsunto(s)
Enfermedades de los Gatos/etiología , Hongos Mitospóricos , Micosis/veterinaria , Animales , Gatos , Granuloma/etiología , Granuloma/parasitología , Granuloma/patología , Granuloma/veterinaria , Masculino , Micosis/complicaciones , Micosis/etiología , Micosis/patología , Enfermedades Nasales/parasitología , Enfermedades Nasales/patología , Enfermedades Nasales/veterinariaRESUMEN
One hundred eighty seven dogs from which fibrous connective tissue sarcomas had been excised were studied until death or for at least 3 years after surgery. Dogs with a skin fibrosarcoma had a median survival time of 80 weeks, compared with 140 weeks for animals with haemangiopericytoma in similar sites, this difference being statistically significant. However, the difference in survival time between the two histologic types disappeared when tumours with a similar mitotic index were compared. Dogs with a tumour of mitotic index 9 or more had a median survival time of 49 weeks, compared with 118 weeks for those with a tumour of mitotic index less than 9, regardless of tumour morphology. Tumour recurrence rates of 62% and 25% respectively for the two groups were also significantly different.